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Abstract 
 Aim: 
To determine the incidence of clinically unrecognized critical congenital heart disease 
(CCHD) in the newborns by using pulse oximetric screening. 
 Methods: 
Pulse oximetry was performed on clinically normal newborns at 24-48 hours of age. If 
screening oxygen saturation (SpO2) was below 95%, echocardiography was then 
performed. Data regarding true and false positives as well as negatives were 
collected and analyzed. 
 Results: 
Pulse-oximetric screening was performed on 1847 clinically normal newborns. Low 
SpO2 (<95%) was found in three babies two of them had CCHD, including one with 
transposition of the great vessels, one with complete atrioventricular canal with 
moderate tricuspid regurgitation (sensitivity: 100%; specificity: 99.8%; positive 
predictive value: 100%; negative predictive value: 100%; accuracy: 99.8%). 
 Conclusions: 
In addition to routine physical examination in the newborn infants pulse oximetry may 
improve the early diagnosis CCHD in the newborn. If oxygen saturation in clinically 
normal newborns is below 95% at 24-48 hours of age, referral to a cardiology unit is 
suggested. 
MeSH: Heart Defects, Infant, Newborn, Neonatal Screening/*methods, 
Congenital/complications/*diagnosis Oximetry 
C Ruangritnamchai, W Bunjapamai, and B Pongpanich. Pulse oximetry screening for clinically 
unrecognized critical congenital heart disease in the newborns. Images Paediatr Cardiol. 2007 Jan-Mar; 
9(1): 10–15.  
 11 
 
Introduction 
The incidence of congenital heart diseases (CHD) is 8-10 per 1,000 live births.1,2,3,4,5 
Early diagnosis of CHD is important because the delayed diagnosis of severe CHD 
can lead to cardiac failure, cardiovascular collapse and even death. Many infants 
died without the diagnosis of CHD.6 Routine neonatal examinations fails to detect 
more than 50% of infants with CHD.7,8,9,10,11 Many neonates with CHD have no signs 
that can be detected by clinical examination. Critical congenital heart diseases 
(CCHD) in the newborn may have borderline low oxygen saturations unrecognized 
clinically. This fact has led some to explore the possibility of screening all newborn 
babies with pulse oxygen oximetry in addition to the usual routine physical 
examination.12,13,14 In developing countries with inadequate medical personnel, this 
method can be very helpful in early detection of CCHD. Our study is designed to 
determine the incidence of clinically unrecognized CCHD by using pulse oximetric 
screening. 
 
Methods 
All infants born aged 24-48 hours at Synphaet Hospital during September 2004 to 
September 2006 were clinically evaluated. Only clinically normal newborns were 
included in the study. Exclusion criteria were any of the following abnormalities on 
physical examination: cyanosis, tachypnea, grunting, nasal flaring, chest retraction, 
significant heart murmur, active precordium, and diminished pulse. Pulse oximetry 
was performed using the Masimo Set pulse oximeter model Radical. Measurements 
were performed by the nurses on the right hand and one foot. O2 saturation (SpO2) 
below 95% underwent additional evaluation by echocardiography. CCHD was 
defined as a lesion that would likely require surgical correction during the first few 
months of life. 
 
Results 
During the study period there were 1,881 live born infants at Synphaet Hospital. 
Twenty-six neonates who met the exclusion criteria were excluded. Eight of these 
neonates had CHD (Figure 1). 
There were 8 neonates no SpO2 measurement. All of them were well on our well 
baby follow up record. Oximetry screening was performed on 1,847 clinically normal 
born infants. There were three infants with SpO2 below 95%. Two of them had 
CCHD, including one patient with transposition of the great vessels (TGV), one 
patient with complete atrioventricular canal (AV canal) & moderate tricuspid 
regurgitation (TR). The mean O2 saturation of normal newborns (SpO2 ≥ 95%) was 
98.1% and was 82.5% in the low SpO2 group (Table 1). 
There were 11 infants with congenital heart disease in this group of infant during this 
study period, the incidence of CHD was 5.8 per 1000 live births and CCHD was 1.08 
per 1000. A pulse oximetry cut-off value of below 95% showed 100% sensitivity, 
99.8% specificity, 100% positive predictive value, 100% negative predictive value 
and accuracy of 99.8% in identifying CCHD (Table 2). 
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Figure 1 Lists of patients, type of CCHD, and method of detection 
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Table 1 Comparision of Results of Pulse Oximetry Screening between well 
Saturation (≥95%) and low Saturation (<95%) groups 
 
 
Table 2 Results of Pulse Oximetry Screening for CCHD. Synphaet Hospital 
 
 
Discussion 
The reported incidence of CHD was 8-10 per 1000 live births.1,2,3,4,5 The incidence 
CCHD is agreeable with the previous study.13 To determine the sensitivity, specificity, 
predictive value, and accuracy of a program of pulse oximetry screening in 
asymptomatic newborns for CCHD , the previous study reported of the effectiveness 
of pulse oximetry screening for CHD in asymptomatic newborns (Sensitivity: 60%; 
specificity: 99.95%; positive predictive value: 75%; negative predictive value: 
99.98%; accuracy: 99.97%).13 The low sensitivity in this study was because they had 
included non critical CHD in their calculation. However, other study revealed that 
systematic screening for CCHD with high accuracy required a new generation 
oximeter, and comparison of saturation values from the right hand and one foot 
substantially improves the detection of CCHD (Sensitivity: 98.5%; specificity: 96.0%; 
positive predictive value: 89.0%; negative predictive value: 99.5%).15 Our efficacy 
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data is very closed to the number of other study.15 The cost of pulse oximetry 
screening is minimal. Although the same disposable probe was used on multiple 
cases, alcohols cleaning between cases were emphasized and yet no evidence of 
infection was found. One limitation of the study is that the number of screened 
neonates are too small and no case of coarctation of aorta to validate the difference 
of oxygen saturation in the right arm and leg. 
 
Conclusion 
This study demonstrated the use of noninvasive, cost-effectiveness tool which is 
pulse oximetry screening adjunct to routine neonatal examination for detecting CCHD 
in clinically normal newborns that were born at Synphaet Hospital during 24 months 
period. 
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